Agree! The only short term announcements I am looking at are:
1. Positive FDA meeting on Ph3, simple trial design, lower numbers
2. Finding out what the non-disclosed disorders are for 2591
3. Acadia hitting it out of the park with Q3 with Daybue, would love for them to come over guidance somehow.
4. Acadia getting approval in Canada for Daybue
Obviously a lot more to happen in 2025 but in the short term these are we can expect and as SH it is good to keep our expectations inline with what the company has outlined.
Share Price, page-11803
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.61 |
Change
-0.200(1.45%) |
Mkt cap ! $1.751B | |||
| Open | High | Low | Value | Volume |
| $13.82 | $13.91 | $13.60 | $1.236M | 90.01K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 1724 | $13.59 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.61 | 225 | 7 |
View Market Depth
| Last trade - 11.06am 11/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |